Dr.Ninthujah Kanageswaran
About Dr.Ninthujah Kanageswaran
Dr. Ninthujah Kanageswaran is a Senior Regional Project Manager CV at Bristol Myers Squibb with a robust background in molecular biology and extensive experience in project management within the cardiovascular sector.
Current Title at Bristol Myers Squibb
Dr. Ninthujah Kanageswaran currently holds the position of Senior Regional Project Manager CV at Bristol Myers Squibb. In this role, she is responsible for overseeing regional cardiovascular projects, utilizing her extensive background in both academic research and project management.
Career Path at Bristol Myers Squibb
Dr. Ninthujah Kanageswaran has been with Bristol Myers Squibb for over five years. She started as a Regional Project Coordinator CV from 2018 to 2019, progressed to Regional Project Manager CV from 2019 to 2022, and currently serves as the Senior Regional Project Manager CV. Her career trajectory within the company highlights her advancement in project management within the cardiovascular sector.
Academic Background
Dr. Ninthujah Kanageswaran studied at Ruhr University Bochum, where she earned her degree in Biologie/biologische Wissenschaften, allgemein, and achieved a doctorate (Dr) from 2011 to 2015. She also studied Biologie, allgemein, at Lehrstuhl für Zellphysiologie, Ruhr-Uni-Bochum, achieving her Promotion.
Experience at Ruhr-Universität Bochum
Dr. Ninthujah Kanageswaran began her career in academia at Ruhr-Universität Bochum. She worked as a Wissenschaftliche Mitarbeiterin at Lehrstuhl für Zellphysiologie from 2010 to 2015. Additionally, she served as a Forschende Doktorandin in Molecular Biology from 2011 to 2015. Her work centered around cellular physiology and molecular biology.
Transition to Pharmaceutical Industry
Bringing her strong academic background and research experience, Dr. Ninthujah Kanageswaran transitioned from academia to the pharmaceutical industry. She joined Bristol Myers Squibb and has been involved in project management, specifically within the cardiovascular sector, for several years. Her expertise in molecular biology and research has been instrumental in her roles in the pharmaceutical industry.